Coalescence Partners Investment Management portfolio
Concentrated managerType not verifiedPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 14, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Coalescence Partners Investment Management reported a $341M portfolio of 12 positions to the SEC as of the end of Q2 2026. Its largest positions are TSM, BX, NVDA. During the quarter it opened Asml Holding and exited Martin Marietta Materials.
Sections with a free account
What changed this quarter
12 positions with a change (1 new, 2 added to, 8 trimmed, 1 sold). 11 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Taiwan Semiconductor Manufacturing−45%fewer sharesReduced25.7% → 26.9%
- Asml Holding+5.9 ppof portfolioNew— → 8.1%
- NVIDIA−47%fewer sharesReduced10.9% → 9.1%
- Fair Isaac−53%fewer sharesReduced9.3% → 6.7%
- S&P Global−52%fewer sharesReduced10.8% → 6.7%
- Moody's−50%fewer sharesReduced9.8% → 6.9%
- Martin Marietta Materials−3.9 ppof portfolioSold out3.9% → —
- TransDigm Group−32%fewer sharesReduced7.1% → 7.6%
- Visa−45%fewer sharesReduced4.1% → 3.5%
- Mastercard−40%fewer sharesReduced4.0% → 3.4%
- Idexx Laboratories+44%more sharesIncreased2.3% → 4.1%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- Taiwan Semiconductor ManufacturingTSM26.9%
- BlackstoneBX11.2%
- NVIDIANVDA9.1%
- ASML HoldingASML8.1%
- TransDigm GroupTDG7.6%
- Moody'sMCO6.9%
- S&P GlobalSPGI6.7%
- Fair IsaacFICO6.7%
- DanaherDHR5.8%
- Idexx LaboratoriesIDXX4.1%
- VisaV3.5%
- MastercardMA3.4%
“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.
Portfolio by sector
- ● Information Technology 51%
- ● Financials 32%
- ● Health Care 10%
- ● Industrials 8%
How its portfolio changed (8 quarters)
Q2 2026: 12
Q2 2026: 93%
Q2 2026: 27.8%
Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Type not verified. It meets the portfolio criteria of a concentrated manager, but its type is not verified: we found no official document that is enough to say what kind of entity it is. It may be an investment firm, but also an adviser adding up client accounts, a bank or a family vehicle. It counts in the tallies like the rest; keep that in mind when reading it. How the type is assigned
Managers of a similar size
A 13F portfolio value between a third and three times this one, whatever the type of filer. It is not a comparison of what they hold.
- MuhlenkampInvestment firm · $345M
- Matthew 25 ManagementInvestment firm · $345M
- RR Advisors$346M
- Weybosset Research & Management$347M
- Stonehill Capital ManagementInvestment firm · $350M
- Wilson Asset Management (international) PTY$350M